Approval · Notice of Compliance 11730 · 2010
ULORIC: Notice of Compliance 11730
Issued September 22, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11730
- Date
- September 22, 2010
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Xanthine oxidase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ULORIC | 02357380 | Cancelled Post Market |
Medicinal ingredients
- FEBUXOSTAT 80 MG per TAB